Epbriv 0.44mg Injection
By Epbriv
Rx
2ml Injection in a Vial

Composition
Eribulin Mesylate(0.44mg)

Manufacturer - Hetero Healthcare Limited
S.no: 80-84, Melange towers, PatrikaNagar,Madhapur,Hyderabad. Telangana-500081.

Expires on or after
August, 2025

liver
When using Epbriv 0.44mg Injection, it is important to be cautious if you have liver disease. Patients with liver issues may require a dose adjustment when using this medication. It is advisable to consult your doctor before starting treatment with Epbriv 0.44mg Injection to ensure its safe use in individuals with liver conditions.

kidney
Epbriv 0.44mg Injection should be used carefully in people with kidney problems. Adjusting the dose might be necessary. Always seek advice from your doctor.

alcohol
It is not known if it is safe to drink alcohol with Epbriv 0.44mg Injection. Consult your doctor when consuming alcohol with this medication.

driving
When using Epbriv 0.44mg Injection, be cautious while driving as it may reduce alertness, cause vision changes, or lead to drowsiness and dizziness. Avoid driving if experiencing these effects.

pregnancy
Epbriv 0.44mg Injection is not safe to use during pregnancy due to the risk it poses to the developing baby. However, in certain life-threatening situations, a doctor may prescribe it if the benefits outweigh the potential risks. It is important to consult your doctor before using this medication during pregnancy.

breastfeeding
Caution should be taken while breastfeeding and using Epbriv 0.44mg Injection, as it is considered unsafe during this period, with risks of potential toxicity to the baby.
Habit Forming | No |
Chemical Class | Synthetic analogue of halichondrin B |
Therapeutic Class | - |
Action Class | Antimicrotubule agents- Non Taxanes |
₹22000
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 11-Feb-2025